These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 22974902)
1. Liver transplantation for massive hepatomegaly due to polycystic liver disease: an extreme case. Gringeri E; D'Amico FE; Bassi D; Mescoli C; Bonsignore P; Boetto R; Lodo E; Noaro G; Polacco M; D'Amico F; Boccagni P; Zanus G; Brolese A; Cillo U Transplant Proc; 2012 Sep; 44(7):2038-40. PubMed ID: 22974902 [TBL] [Abstract][Full Text] [Related]
2. [Orthotopic liver transplantation for polycystic liver disease with massive hepatomegaly]. Dreger NM; Kaiser GM; Treckmann JW; Mathé Z; Benkö T; Paul A Dtsch Med Wochenschr; 2013 Nov; 138(47):2407-9. PubMed ID: 24221975 [TBL] [Abstract][Full Text] [Related]
3. Choice of transplantation techniques and indications for liver transplantation in polycystic liver disease in patients with no signs of end-stage liver disease. Kornasiewicz O; Dudek K; Bugajski M; Najnigier B; Krawczyk M Transplant Proc; 2008 Jun; 40(5):1536-8. PubMed ID: 18589146 [TBL] [Abstract][Full Text] [Related]
4. Massive cystic hepatomegaly in a female patient with polycystic kidney disease treated by combined hepatic and renal transplantation. Taylor JE; Calne RY; Stewart WK Q J Med; 1991 Sep; 80(293):771-5. PubMed ID: 1754677 [TBL] [Abstract][Full Text] [Related]
5. Living donor liver transplantation in polycystic liver disease. Mekeel KL; Moss AA; Reddy KS; Douglas DD; Vargas HE; Carey EJ; Byrne TJ; Harrison ME; Rakela J; Mulligan DC Liver Transpl; 2008 May; 14(5):680-3. PubMed ID: 18433036 [TBL] [Abstract][Full Text] [Related]
10. [Orthotopic liver transplantation in therapy of advanced polycystic liver disease]. Klupp J; Bechstein WO; Lobeck H; Neuhaus P Chirurg; 1996 May; 67(5):515-21. PubMed ID: 8777881 [TBL] [Abstract][Full Text] [Related]
11. Liver and kidney transplantation for polycystic liver and kidney-renal function and outcome. Ueno T; Barri YM; Netto GJ; Martin A; Onaca N; Sanchez EQ; Chinnakotla S; Randall HB; Dawson S; Levy MF; Goldstein RM; Klintmalm GB Transplantation; 2006 Aug; 82(4):501-7. PubMed ID: 16926594 [TBL] [Abstract][Full Text] [Related]
12. Use of model for end-stage liver disease exception points for early liver transplantation and successful reversal of hepatic myelopathy with a review of the literature. Caldwell C; Werdiger N; Jakab S; Schilsky M; Arvelakis A; Kulkarni S; Emre S Liver Transpl; 2010 Jul; 16(7):818-26. PubMed ID: 20583082 [TBL] [Abstract][Full Text] [Related]
14. Combined liver-kidney transplantation: the experience of the University of Bologna and the case of preoperative positive cross-match. Faenza A; Fuga G; Nardo B; Varotti G; Faenza S; Stefoni S; D'Arcangelo GL; Mosconi G; Feliciangeli G; Pinna AD Transplant Proc; 2006 May; 38(4):1118-21. PubMed ID: 16757282 [TBL] [Abstract][Full Text] [Related]
15. The utility of the model for end-stage liver disease score: a reliable guide for liver transplant candidacy and, for select patients, simultaneous hospice referral. Medici V; Rossaro L; Wegelin JA; Kamboj A; Nakai J; Fisher K; Meyers FJ Liver Transpl; 2008 Aug; 14(8):1100-6. PubMed ID: 18668666 [TBL] [Abstract][Full Text] [Related]
16. Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation. Machicao VI; Srinivas TR; Hemming AW; Soldevila-Pico C; Firpi RJ; Reed AI; Morelli GJ; Nelson DR; Abdelmalek MF Liver Transpl; 2006 May; 12(5):754-61. PubMed ID: 16528716 [TBL] [Abstract][Full Text] [Related]
18. Liver retransplantation: a single-centre experience. Ma Y; Wang GD; He XS; Li JL Chin Med J (Engl); 2008 Oct; 121(20):1987-91. PubMed ID: 19080261 [TBL] [Abstract][Full Text] [Related]
19. [Anesthesia for living-donor liver transplantation in a patient with adult polycystic liver disease]. Higashibeppu N; Oida E; Furutani H; Segawa H; Adachi T; Fukuda K Masui; 2003 Mar; 52(3):264-7. PubMed ID: 12703068 [TBL] [Abstract][Full Text] [Related]
20. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality. Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]